Asan, F. Et Al. 2022. Treatment of multiple sclerosis-related trigeminal neuralgia with onabotulinumtoxinA. HEADACHE , vol.62, no.10 , 1322-1328.

Asan, F., GÜNDÜZ, A., TÜTÜNCÜ, M., UYGUNOĞLU, U., SAVRUN, F., SAİP, S., ... Siva, A.(2022). Treatment of multiple sclerosis-related trigeminal neuralgia with onabotulinumtoxinA. HEADACHE , vol.62, no.10, 1322-1328.

Asan, Furkan Et Al. "Treatment of multiple sclerosis-related trigeminal neuralgia with onabotulinumtoxinA," HEADACHE , vol.62, no.10, 1322-1328, 2022

Asan, Furkan Et Al. "Treatment of multiple sclerosis-related trigeminal neuralgia with onabotulinumtoxinA." HEADACHE , vol.62, no.10, pp.1322-1328, 2022

Asan, F. Et Al. (2022) . "Treatment of multiple sclerosis-related trigeminal neuralgia with onabotulinumtoxinA." HEADACHE , vol.62, no.10, pp.1322-1328.

@article{article, author={Furkan Asan Et Al. }, title={Treatment of multiple sclerosis-related trigeminal neuralgia with onabotulinumtoxinA}, journal={HEADACHE}, year=2022, pages={1322-1328} }